FOXO TECHNOLOGIES INC. Business Acquisition, Pro Forma Earnings Per Share, Diluted
FOXO TECHNOLOGIES INC. (FOXO) reported Business Acquisition, Pro Forma Earnings Per Share, Diluted of -$0.76 per share for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted · last filed 2026-08-14
- FOXO TECHNOLOGIES INC. business acquisition, pro forma earnings per share, diluted for the quarter ending 2026-03-31 was -$0.76.
- FOXO TECHNOLOGIES INC. business acquisition, pro forma earnings per share, diluted for the quarter ending 2025-06-30 was -$690.74.
- FOXO TECHNOLOGIES INC. business acquisition, pro forma earnings per share, diluted for the quarter ending 2024-09-30 was -$0.22.
- FOXO TECHNOLOGIES INC. business acquisition, pro forma earnings per share, diluted for the quarter ending 2024-06-30 was -$6.05.
- FOXO TECHNOLOGIES INC. business acquisition, pro forma earnings per share, diluted for fiscal 2025 was -$0.13.
- FOXO TECHNOLOGIES INC. business acquisition, pro forma earnings per share, diluted for fiscal 2024 was -$20.93.
- FOXO TECHNOLOGIES INC. business acquisition, pro forma earnings per share, diluted for fiscal 2023 was -$4.89.
| Period end | Business Acquisition, Pro Forma Earnings Per Share, Diluted 3 month | Business Acquisition, Pro Forma Earnings Per Share, Diluted 3 month as first filed | Business Acquisition, Pro Forma Earnings Per Share, Diluted 6 month | Business Acquisition, Pro Forma Earnings Per Share, Diluted 6 month as first filed | Business Acquisition, Pro Forma Earnings Per Share, Diluted 9 month | Business Acquisition, Pro Forma Earnings Per Share, Diluted 12 month | Business Acquisition, Pro Forma Earnings Per Share, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | -$0.76 10-Q · filed 2026-05-15 | ||||||
| 2025-12-31 | -$0.13 10-K · filed 2026-04-15 | ||||||
| 2025-06-30 | -$690.74 10-Q · filed 2026-08-14 | -$2162.39 10-Q · filed 2026-08-14 | |||||
| 2024-12-31 | -$20.93 10-K · filed 2026-04-15 | -$1.11 10-K · filed 2025-04-15 | |||||
| 2024-09-30 | -$0.22 10-Q · filed 2024-11-19 | -$0.74 10-Q · filed 2024-11-19 | |||||
| 2024-06-30 | -$6.05 10-Q · filed 2025-08-19 | -$0.24 10-Q · filed 2024-08-19 | -$12.19 10-Q · filed 2025-08-19 | -$0.51 10-Q · filed 2024-08-19 | |||
| 2024-03-31 | -$6.15 10-Q/A · filed 2025-08-19 | -$0.23 10-Q · filed 2024-06-28 | |||||
| 2023-12-31 | -$4.89 10-K · filed 2025-04-15 | ||||||
| 2023-09-30 | -$0.73 10-Q · filed 2024-11-19 | -$4.83 10-Q · filed 2024-11-19 | |||||
| 2023-06-30 | -$3.59 10-Q · filed 2024-08-19 | -$5.99 10-Q · filed 2024-08-19 | |||||
| 2023-03-31 | -$1.50 10-Q · filed 2024-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |